Who invested in CoLucid Pharmaceuticals?
CoLucid Pharmaceuticals's investors include Domain Associates, Pappas Ventures, Care Capital, Triathlon Medical Venture Partners and Pearl Street Venture Funds, and 3 more on record.
United States · Series C startup
5 rounds we have observed, with the 8 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$81Mraised across 5 rounds since 2008, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding recordSEC filing: $37M sold, first sale Jan 2015
Reported by prnewswire.comSEC filing: $3.5M sold, first sale Feb 2011
No investor was named in the report.
Reported by sec.govSEC filing: $2.0M sold, first sale Feb 2011
No investor was named in the report.
Reported by sec.govSEC filing: $9.2M sold, first sale Jan 2009
From a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
CoLucid Pharmaceuticals's investors include Domain Associates, Pappas Ventures, Care Capital, Triathlon Medical Venture Partners and Pearl Street Venture Funds, and 3 more on record.
CoLucid Pharmaceuticals has raised $81M across 5 rounds since 2008.
CoLucid Pharmaceuticals's most recent round was a Series C of $37M in Jan 2015.
Its most recent round, $37M in Jan 2015, is also its largest on record.
CoLucid Pharmaceuticals's first round on record, in Jul 2008, was backed by Domain Associates, Pappas Ventures and Care Capital and 2 others.
CoLucid Pharmaceuticals's latest named round is a Series C, in Jan 2015.
CoLucid Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.